N
Naomi Brosnahan
Researcher at University of Glasgow
Publications - 26
Citations - 1962
Naomi Brosnahan is an academic researcher from University of Glasgow. The author has contributed to research in topics: Weight loss & Medicine. The author has an hindex of 9, co-authored 17 publications receiving 1197 citations. Previous affiliations of Naomi Brosnahan include Glasgow Royal Infirmary.
Papers
More filters
Journal ArticleDOI
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean,Wilma S Leslie,Alison C. Barnes,Naomi Brosnahan,George Thom,Louise McCombie,Carl Peters,Sviatlana Zhyzhneuskaya,Ahmad Al-Mrabeh,Kieren G. Hollingsworth,Angela M. Rodrigues,Lucia Rehackova,Ashley J. Adamson,Falko F. Sniehotta,John C. Mathers,H. M. Ross,Yvonne McIlvenna,Renae J. Stefanetti,Michael I. Trenell,Paul Welsh,Sharon Kean,Ian Ford,Alex McConnachie,Naveed Sattar,Roy Taylor +24 more
TL;DR: The findings show that, at 12 months, almost half of participants achieved remission to a non-diabetic state and off antidiabetic medications, from baseline to 12 months.
Journal ArticleDOI
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E. J. Lean,Wilma S Leslie,Alison C. Barnes,Naomi Brosnahan,George Thom,Louise McCombie,Carl Peters,Sviatlana Zhyzhneuskaya,Ahmad Al-Mrabeh,Kieren G. Hollingsworth,Angela M. Rodrigues,Lucia Rehackova,Ashley J. Adamson,Falko F. Sniehotta,John C. Mathers,H. M. Ross,Yvonne McIlvenna,Paul Welsh,Sharon Kean,Ian Ford,Alex McConnachie,Claudia-Martina Messow,Naveed Sattar,Roy Taylor +23 more
TL;DR: Sustained remission was linked to the extent of sustained weight loss, and the DiRECT programme sustained remissions at 24 months for more than a third of people with type 2 diabetes.
Journal ArticleDOI
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.
Wilma S Leslie,Ian Ford,Naveed Sattar,Kieren G. Hollingsworth,Ashley J. Adamson,Falko F. Sniehotta,Louise McCombie,Naomi Brosnahan,H. M. Ross,John C. Mathers,Carl Peters,George Thom,Alison C. Barnes,Sharon Kean,Yvonne McIlvenna,Angela M. Rodrigues,Lucia Rehackova,Sviatlana Zhyzhneuskaya,Roy Taylor,Michael E. J. Lean +19 more
TL;DR: The Diabetes Remission Clinical Trial (DiRECT) was designed to determine whether a structured, intensive, weight management programme, delivered in a routine Primary Care setting, is a viable treatment for achieving durable normoglycaemia.
Journal ArticleDOI
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity.
Michael E. J. Lean,Naomi Brosnahan,Philip McLoone,Louise McCombie,Anna Bell Higgs,H. M. Ross,Mhairi Mackenzie,Eleanor Grieve,Nick Finer,John P. D. Reckless,David Haslam,Billy Sloan,David S. Morrison +12 more
TL;DR: A care package within routine primary care for severe obesity, including LELD, food reintroduction, and weight-loss maintenance, was well accepted and achieved a 12-month-maintained weight loss of ≥15 kg for one-third of all patients entering the programme.
Journal ArticleDOI
Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
George Thom,Claudia-Martina Messow,Wilma S Leslie,Alison C. Barnes,Naomi Brosnahan,Louise McCombie,Ahmad Al-Mrabeh,Sviatlana Zhyzhneuskaya,Paul Welsh,Naveed Sattar,Robert W. Taylor,Michael E. J. Lean +11 more
TL;DR: To identify predictors of type 2 diabetes remission in the intervention arm of DiRECT (Diabetes Remission Clinical Trial), the objective was to find out which predictors led to remission and which did not.